Autocrine secretion of Fas ligand shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes

Cancer Research
Kristian HallermalmJelena Levitskaya

Abstract

Mechanisms responsible for resistance of tumors to death receptor-mediated damage by cytotoxic lymphocytes are not well understood. Uveal melanoma cells expressed Fas but were insensitive to Fas triggering induced by bystander cytotoxic T lymphocytes or a Fas-specific agonistic antibody; this could not be ascribed to tumor counterattack against T cells or general resistance of the tumors to apoptosis. Treatment with inhibitors of metalloproteases rendered uveal melanomas sensitive to Fas-mediated cytotoxicity. Metalloprotease inhibitors did not affect the expression of Fas but increased the surface expression of Fas ligand (FasL), which correlated with the disappearance of soluble FasL from culture supernatants of tumor cells. FasL eluted from the surface of uveal melanomas specifically inhibited cytotoxic T lymphocyte lysis of tumor cells pretreated with an inhibitor of metalloproteases. In addition to uveal melanomas, a number of other tumor cell lines of various cellular origins were sensitized to Fas-mediated cytotoxicity by metalloprotease inhibitors. Our results show that autocrine secretion of FasL shields tumor cells from Fas-mediated killing by cytotoxic lymphocytes. This defines a novel mechanism of tumor escape from ...Continue Reading

References

Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·S TorsteinsdottirE Klein
Sep 1, 1996·The Journal of Experimental Medicine·J O'ConnellF Shanahan
Jan 14, 1998·Nature Medicine·M TanakaS Nagata
Mar 23, 1999·Nature Medicine·J O'ConnellF Shanahan
Jun 11, 1999·The American Journal of Pathology·M S ShinS H Lee
Jun 22, 2000·International Journal of Cancer. Journal International Du Cancer·S A RabbaniD W Morgan
Nov 8, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·L R SchurmansR E Toes
Apr 3, 2002·Seminars in Cancer Biology·Barbara SeligerSoldano Ferrone
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Oct 31, 2002·Nature Immunology·Hung T Khong, Nicholas P Restifo
Dec 18, 2002·Cytokine & Growth Factor Reviews·Harald WajantPeter Scheurich
Apr 22, 2003·Journal of Cellular Physiology·Angel Garcia-LoraFederico Garrido

❮ Previous
Next ❯

Citations

Jun 6, 2006·Cancer Immunology, Immunotherapy : CII·Simona VertuaniJelena Levitskaya
Jun 16, 2007·Cancer Immunology, Immunotherapy : CII·Diego O CrociO Graciela Scharovsky
Mar 4, 2011·Cell Death & Disease·F Guardiola-SerranoA-O Hueber
Mar 16, 2006·Pharmacogenetics and Genomics·Chunying LiQingyi Wei
Mar 10, 2007·The British Journal of Ophthalmology·Marta E PolakIan A Cree
Mar 12, 2010·World Journal of Gastroenterology : WJG·Qian LiGui-Ying Zhang
Apr 8, 2010·Ocular Immunology and Inflammation·Kyle C McKenna, Peter W Chen
Mar 11, 2005·Expert Opinion on Therapeutic Targets·Andreas LinkermannOttmar Janssen
Jun 29, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Martin GrimmAna Maria Waaga-Gasser
Jul 1, 2009·Progress in Retinal and Eye Research·Jerry Y Niederkorn
Mar 5, 2016·Cell Death and Differentiation·D de MiguelL Martinez-Lostao
Jan 1, 2008·Immunology Letters·Stefanie Gross, Peter Walden
Aug 13, 2014·Pigment Cell & Melanoma Research·Jason J LukeRichard D Carvajal
Oct 3, 2009·Annals of the New York Academy of Sciences·Tobias Schatton, Markus H Frank
Oct 7, 2005·Critical Reviews in Oncology/hematology·Daniel H Fowler
May 1, 2007·Expert Opinion on Therapeutic Targets·Konstantinos Drosopoulos, Alexander Pintzas
Nov 3, 2016·Nature Reviews. Clinical Oncology·Malte MohmeKlaus Pantel
Nov 20, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B Bonavida, S Chouaib
Jun 4, 2010·Anais Brasileiros De Dermatologia·Georgi Tchernev, Pietro Nenoff
Aug 30, 2019·Cells·Elisabetta Rossi, Francesco Fabbri
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anna De GeerJelena Levitskaya
Nov 22, 2019·Frontiers in Oncology·Maria Sofia BasileMichele Reibaldi
Nov 8, 2005·World Journal of Gastroenterology : WJG·Qiang ZhuHong-Bo Wang
Jun 1, 2016·Melanoma Management·Dae Won KimSapna P Patel
Apr 13, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Gregory LizéePatrick Hwu
Jul 15, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Marco de BruynEdwin Bremer
Nov 6, 2020·Therapeutic Advances in Medical Oncology·Yongyun LiXianqun Fan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis